أنواع العلاجات التي تحتوي على الكورتزون بنسب عالية

[خويلد الجزائري]

نسال الله لك السداد على موضوعك الذي يستحق ان نستعيده من حين لاخر لما له من فادة في حياتنا الصحية .......

[بنت العم]

ياريت لو كان بالعربي ...مو واضح بالنسبه لي
مشكووووور اخوي على الموضوع الرائع

[reem50]

لو تبتدي اخوي الغالي بالادويه التي تعرفها وفيها كرتزون بنسبه عاليه وكل عضو يضيف مامر به من ادويه الكورتزون لتكون في النهايه قائمه نحتفظ بها ولانقربها ابدا ولك الاجر والثواب

[moi]

السلام عليكم و رحمة الله تعالى و بركاته
الى كل الاخوة الذين لم يفهمو الفرنسية أنا قمت بتحويل اللغة انجليزي عسى أن تفيدهم
على فكرة أنا قمت بعملية النسخ و ترجمته عل أحد المواقع لأني أنا و الانجليزي ليس بيننا ود

To facilitate their regulation, we classified the glucocorticoïdes according to their mode of administration, by general way and local way. The same product can appear in several tables.
The table which follows indicates the glucocorticoïdes being able to be managed by way general, oral or parenteral (intramuscular or intravenous) and local like their coefficient of glucocorticoïde activity.
The coefficient of glucocorticoïde activity indicates the importance of the glucocorticoïde effect various products: the dexaméthasone is 25 times more effective than hydrocortisone or 1 Mg of dexaméthasone is as effective as 25 Mg of hydrocortisone.
Cortisone
CORTISONE ROUSSEL* CP 10 Mg
Hydrocortisone
1 HYDROCORTISONE ROUSSEL* CP 10 Mg, Inj.
HYDROCORTISONE UPJOHN* Inj.
Prednisone
4 CORTANCYL* CP 1,5,20 Mg
Prednisolone
4 SOLUPRED* CP 5 and 20 Mg, WP
HYDROCORTANCYL*
CP 5 Mg, Inj.
Methyl
prednisolone
5
MÉ DROL* CP 4 and 16 Mg
SOLUMÉ DROL* Inj.
DEPOMÉ DROL* Inj.
Triamcinolone
5
KENACORT RETARD* Inj.
HEXATRIONE* Inj.
Dexaméthasone
25 DECTANCYL* CP 0,5 Mg, Inj
Bétaméthasone
25 BETNESOL* CP 0,5 Mg, Inj.
CÉ LESTÈ NE* CP 0,5 Mg, Inj.
DIPROSTÈ NE* Inj.
Cortivazol
50 ALTIM* Inj.
The glucocorticoïdes in the form of injectable suspension are managed by way local, intra-articular and periarticular, sometimes intramuscular but never by intravenous way.
Cortisone (CORTISONE ROUSSEL*) is used only in the substitute treatment of the suprarenal insufficiency of the disease of Addison. It is transformed in the organization into cortisol called also hydrocortisone, its ****bolite credit. This activation by reduction is carried out on the level of the liver.
The glucocorticoïdes presented out of bottles pressurized for aerosol and intended for the treatment of asthma are the béclométhasone, the flunisolide and the budésonide. The fluticasone, also intended for the treatment of asthma, is presented in the form of powder for oral inhalation
Béclométasone BÉ CLOJET*
BÉ COTIDE*
PROLAIR*
Flunisolide
BRONILIDE 250
Budésonide
PULMICORT*
Fluticasone
FLIXOTIDE*
The glucocorticoïdes out of bottle pulverizer are intended for the treatment of the rhinitides.
Béclométasone
BÉ CONASE*
Prednisolone
SOLUCORT ORL*
Tixocortol
PIVALONE*
Flunisolide
NASALIDE*
Mométasone
NASONEX*
The creams and pomades containing of corticoids associated or not with antibiotics are called dermocorticoïdes. The activity of each dermocorticoïde depends on the nature of the glucocorticoïde present, i.e. coefficient of activity, and its expressed concentration en% compared to the excipient, cream or pomade.
Hydrocortisone
HYDROCORTISONE ASTIER*
EFFICORT*
Bétaméthasone
DIPROLÈ NE*
BETNEVAL*
CÉ LESTODERM*
DIPROSONE*
Halcinonide
HALOG crème*
Diflucortolone
NÉ RISONE*
Désoximéthasone
TOPICORTE*
Fluocinonide
TOPSYNE*
Amcinonide
PENTICORT*
Fluocinolone
SYNALAR*
Fluocortolone
ULTRALAN*
Clobétasol
DERMOVAL*
Alclométasone
ACLOSONE*
Désonide
TRIDÉ SONIT 0,25*
LOCAPRED*
The glucocorticoïdes, presented in the form of eye lotions or of ophthalmic pomades, are intended for the treatment of the inflammatory and allergic affections of the former segment of it (conjunctivites, blépharites, keratites, uvéites, sclérites).
Dexaméthasone
MAXIDROL*
Prednisolone
SOLUCORT OPHTA*
Fluorométholone
FLUCON*
Riméxolone
VEXOL*
The risk of these ophthalmic corticoids is the development of an infection, in particular viral (Herpes simplex) or of a cataract or of a glaucome.
There exist also ophthalmic eye lotions and pomades associating
glucocorticoïdes and antibiotics.
The treatments of short duration (lower than one week), even with raised posology, have few undesirable effects.
The risk of appearance of undesirable effects grows with the duration of the treatment and the increase in posology and one can observe various disorders:
a syndrome of comprising Cushing of many demonstrations: redistribution of the lipids on the level of the face, dèmes with retention of water (to be prevented by a mode low in sodium), hypokaliemy, increase in the blood-pressure, aggravation of a diabetes, atrophies, muscular, turbid weakness and fatigability of the menstrual cycle, stop or deceleration of the growth in the child.
a surrénalienne insufficiency at the time of the stop of the treatment, because of setting at rest of corticosuprarenal, even in the child with the birth when the mother was treated during the pregnancy. The stop of the treatment can also involve various demonstrations: fever, myalgias, arthralgies.
osseous disorders: the development of the osteoporosis induced by the glucocorticoïde treatment can be braked by the maintenance of an physical-activity, a supplementation out of calcium and vitamin D, a estroprogestatif treatment after the menopause or possibly by a biphosphonate. In addition, exceptionally a ostéonécrose of the femoral head can be observed.
hoop nets neuropsychic various, difficult to envisage: nervousness, insomnia, depression, aggravation of an epilepsy, increase in the intracranial pressure in the child.
ocular accidents after local government and general: glaucome, cataract.
hematologic modifications: increase in the leucocytes, thrombocytes, reduction in lymphocytes T.
digestive disorders, in particular a risk of ulcer evolving/moving with atypical symptomatology being able to be at the origin of bleedings, as well as pancreatic attacks.
an increase in the risk infectious, bacterial (tuberculosis) or viral (chicken pox, shingles herpes), or mycosic (candidose). The infection generally evolves/moves with low noise, without fever. The vaccination of the people treated by corticoids is disadvised, especially if they are alive vaccines.
delay of growth: managed with the child, in the long run they can involve a delay of growth which can require a treatment by the growth hormone.
exceptionally shocks at the time of their administration by intravenous way, even with the preparations not containing a sulphite.
Medicamentous interactions are possible: the enzymatic inductors by accelerating the degradation of the glucocorticoïdes can reduce their effectiveness.
The risk of undesirable effects of certain drugs antiarythmic, digitalic, anticoagulants, is increased among patients treated by corticoids, probably because of the hypokaliemy. The regulation of a glucocorticoïde to a diabetic can worsen his diabetes and decrease the effectiveness of insulin.
و الله الموفق
أسأل الله العلي القدير أن يشفي الجميع

[خويلد الجزائري]

نسأل الله لك السداد اخي moi على ما قمت به من توضيحات قيمة ............

[moi]

و فيك بارك ربي حبيبي الغالي خويلد
أسأل الله العلي القدير أن يجزيك خير جزاك و يصلح لك أهلك و يرحم والديك رحمة واسعة آمين

[mustafa2003s]

السلام عليكم ورحمة الله وبركاته :
أود ان اشكر كل القائمين على هذا الملتقى ، و أوجه تحية لكل الاعضاء المشاركين ، وأتمنى لهذا الملتقى كل تقدم وتميز لما ينشره من افادة صحية لكل الناس . *

[بوسطن]

السلام عليكم
رواد وزوار المنتدى الطيب
بارك الله فيكم وجزاكم كل الخير للترجمه اخوى moi